title: Response to interferon treatment decreases with epidermal dedifferentiation in condylomas.
abstract: After interferon (IFN) treatment of patients with condyloma acuminatum, groups clinically proven to be responders or nonresponders were selected, and cellular parameters that might influence the clinical response were studied in pretreatment biopsies by reverse transcription polymerase chain reaction (RT-PCR). The nonresponders were found to express higher amounts of cellular proliferative markers, such as proliferating cell nuclear antigen (PCNA), cyclin A, and cdc 2 kinase, but lower levels of growth suppressor genes (TGF-beta 1, TGF-beta 2 and p53) before IFN treatment. The responders retained the epidermal keratinization, except for some signs of hyperproliferation (K6, K16 cytokeratins). In addition, the nonresponders showed a shift in the keratinization pattern to a mucosal or fetal type, as evidenced by high expression of the K18, K6, K16 and K13 cytokeratins but decreased K5, K14 and K10 levels before treatment. The expression of the human papillomavirus (HPV) genes is consistent with these differentiation patterns. The crucial conclusion to be drawn from this study is that those condylomas whose pretreatment phenotype most closely resembles that of normal epidermis respond to IFN treatment, whereas those more akin to nonkeratinizing epithelia fail to respond, i.e. the resistance of condylomas to IFN treatment is correlated with dedifferentiation.
authors.affiliation: Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston 77555, USA.
authors.forename: I
authors.initials: I
authors.lastname: Arany
authors.forename: M M
authors.initials: MM
authors.lastname: Brysk
authors.forename: H
authors.initials: H
authors.lastname: Brysk
authors.forename: S K
authors.initials: SK
authors.lastname: Tyring
mesh_terms: D001483:Base Sequence; D015415:Biomarkers; D002454:Cell Differentiation / Q000235:genetics; D003218:Condylomata Acuminata / Q000473:pathology* / Q000628:therapy* / Q000821:virology; D017931:DNA Primers / Q000235:genetics; D015967:Gene Expression Regulation, Viral; D005814:Genes, Viral; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007633:Keratins / Q000235:genetics; D027383:Papillomaviridae / Q000235:genetics; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism; D017193:Skin Diseases, Viral / Q000473:pathology* / Q000628:therapy* / Q000821:virology
chemical_list: D015415:Biomarkers; D017931:DNA Primers; D012333:RNA, Messenger; D012367:RNA, Viral; D007633:Keratins; D007372:Interferons